RHI Magnesita (RHIM) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
30 Apr, 2026Executive summary
Adjusted EBITDA/EBITA increased approximately 15% year-over-year, driven by self-help initiatives, cost discipline, pricing actions, and supply chain agility.
Global demand for steel and industrial refractories remained weak, with regional variations; steel volumes were flat and industrial project volumes subdued year-over-year.
North America and Latin America delivered strong profit contributions, offsetting weaker results in Europe, where volumes shifted to Q2.
Management continues to execute network optimisation, digitisation, and other self-help measures to support ongoing improvement.
Strong supply chain agility enabled rapid response to geopolitical disruptions, particularly in the Middle East.
Financial highlights
Adjusted EBITDA/EBITA rose by approximately 15% year-over-year, or 46% on a constant currency basis; reported EBIT up 25% (+84% constant currency).
Net debt increased in Q1 due to higher working capital from inventory buildup, but is expected to decline to €1.4 billion by year-end.
Cash conversion for the full year is expected to exceed 90%, supporting deleveraging and strong cash generation.
Steel revenue grew 6% in constant currency, while industrial revenue declined 6%; group revenue up 2% in constant currency, down 5% reported.
Outlook and guidance
Full-year adjusted EBITDA/EBITA guidance reconfirmed at €435 million (constant currency) or €400 million (current FX), with leverage expected to decline to 2.6x by year-end.
EBITDA margin guidance of 11.5% for the year, with 1% from backward integration.
Second quarter and second half expected to be stronger than first quarter/half, with a typical 45%/55% split.
Gradual improvement in steel and industrial demand anticipated, especially in non-ferrous metals.
No significant M&A cash outflows anticipated in 2026, though M&A remains a strategic focus.
Latest events from RHI Magnesita
- Cost actions and M&A drove H2 recovery in 2025, supporting a cautious 2026 outlook.RHIM
Q4 20252 Mar 2026 - Stable revenue and strong cash flow; EBITA guidance reaffirmed despite weak demand.RHIM
H1 20243 Feb 2026 - Margins exceeded guidance despite weak demand; EBITA outlook trimmed amid persistent overcapacity.RHIM
Q3 2024 TU15 Jan 2026 - Solid 2024 results and margin gains despite weak demand; modest growth seen for 2025.RHIM
H2 202416 Dec 2025 - Weak Q1, overcapacity, and trade risks make H2 recovery vital for guidance.RHIM
Q1 2025 TU21 Nov 2025 - Revenue and margins fell on weak demand and pricing, but H2 recovery is expected.RHIM
H1 202516 Nov 2025 - Cost savings and RESCO integration drove margin recovery despite weak demand.RHIM
Q3 2025 TU10 Nov 2025